Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49 Adipogen/Colistin sulfate (USP Grade)/AG-CN2-0065-G005/5 g188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
Adipogen/Colistin sulfate (USP Grade)/AG-CN2-0065-G005/5 g
More Information
Product Details
Synonyms
Polymyxin E; Belcomycin; Colimycin
Product Type
Chemical
Properties
Formula
2(C52H98N16O13) . 5(H2SO4) (unspec.)
MW
2801.7
CAS
1264-72-8
RTECS
TR1500000
Source/Host Chemicals
Isolated from Bacillus polymyxa.
Purity Chemicals
Mixture (primarly colistin A and B).
Appearance
White to off-white powder.
Solubility
Soluble in water.
Biological Activity
Potency (dry basis) ≥15000U/mg
InChi Key
YKQOSKADJPQZHB-QNPLFGSASA-N
Shipping and Handling
Shipping
AMBIENT
Short Term Storage
+4°C
Long Term Storage
+4°C
Handling Advice
Keep cool and dry.
Use/Stability
Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS
Download PDF
Product Specification Sheet
Datasheet
Download PDF
Very potent polymyxin antibiotic.
Has only one amino acid difference compared to polymyxin B.
Antimicrobial.
Targets the lipopolysaccharide (LPS) of the outer membrane of Gram-negative bacteria. Competitively displaces divalent cations (Ca2+ and Mg2+) from the negatively-charged phosphate groups LPS, causing disruption of the membrane. This increases the permeability of the cell envelope, leakage of cell contents, leading to apoptosis and cell death.
Used against multidrug-resistant Gram-negative bacterial infections.
Product References
Antimicrobial drugs, microorganisms, and phagocytes: P.J. van den Broek; Rev. Infect. Dis. 11, 213 (1989) (Review)
Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria: M.E. Evans, et al.; Ann. Pharmacother. 33, 960 (1999) (Review)
The clinical use of colistin in patients with cystic fibrosis: P. Beringer; Curr. Opin. Pulm. Med. 7, 434 (2001) (Review)
Update on antimicrobial agents: new indications of older agents: T.R. Pasquale & J.S. Tan; Expert Opin. Pharmacother. 6, 1681 (2005) (Review)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections: J. Li, et al.; Lancet Infect. Dis. 6, 589 (2006) (Review)
Polymyxin B: similarities to and differences from colistin (polymyxin E): A. Kwa, et al.; Expert Rev. Anti. Infect. Ther. 5, 811 (2007) (Review)
Colistin in the 21st century: R.L. Nation & J. Li; Curr. Opin. Infect. Dis. 22, 535 (2009) (Review)
New information about the polymyxin/colistin class of antibiotics: J. Molina, et al.; Expert Opin. Pharmacother. 10, 2811 (2009) (Review)
Colistin: new lessons on an old antibiotic: D. Yahav, et al.; Clin. Microbiol. Infect. 18, 18 (2012) (Review)